Article | April 21, 2020

Continuous Or Batch: Deciding On The Best Solution For Your Oral Solid Dose Product

Source: Thermo Fisher Scientific

By Jessica Settimi and Eric Jayjock, Thermo Fisher Scientific

Manufacturing of cell and gene therapiesv1

The transition from blockbuster drugs and large-scale production to niche drugs focused on smaller patient populations has driven a greater need for increased flexibility, faster product development, and lower costs in today’s manufacturing processes. One way to achieve these goals is by moving away from traditional batch processing and toward continuous manufacturing, which has begun to attract more interest in the industry over the last decade.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Drug Discovery Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: